CART-immune-related adverse events after BCMA CAR-T therapy
Fuente:
PubMed "nature biotechnology"
Mol Ther Oncol. 2026 Jul 2;34(3):201274. doi: 10.1016/j.omton.2026.201274. eCollection 2026 Sep 17.NO ABSTRACTPMID:42433968 | PMC:PMC13352023 | DOI:10.1016/j.omton.2026.201274